Published December 1998
| Version v1
Miscellaneous
Open
What should be the optimal dose of 131I for remnant ablation in differentiated thyroid cancer?
Creators
- 1. Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi (India)
Description
no abstract available
Files
29067587.pdf
Files
(117.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:b28a4b65cb1e2c620bdb052305190ab0
|
117.0 kB | Preview Download |
Additional details
Publishing Information
- Imprint Title
- International seminar on therapeutic applications of radiopharmaceuticals. Programme. Book of extended synopses
- Imprint Pagination
- 194 p.
- Journal Page Range
- p. 60-63
- Report number
- IAEA-SR--209
Conference
- Title
- International seminar on therapeutic applications of radiopharmaceuticals
- Dates
- 18-22 Jan 1999
- Place
- Hyderabad (India)
INIS
- Country of Publication
- International Atomic Energy Agency (IAEA)
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 29067587
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference, No Abstract
- Descriptors DEI
- CARCINOMAS; CUMULATIVE RADIATION EFFECTS; FRACTIONATED IRRADIATION; IODINE 131; OPTIMIZATION; PATIENTS; RADIATION DOSES; RADIONUCLIDE ADMINISTRATION; RADIOTHERAPY; THYROID
- Descriptors DEC
- ANIMALS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; DAYS LIVING RADIOISOTOPES; DISEASES; ENDOCRINE GLANDS; GLANDS; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; IRRADIATION; ISOTOPES; MAMMALS; MAN; MEDICINE; NEOPLASMS; NUCLEI; ODD-EVEN NUCLEI; ORGANS; PRIMATES; RADIATION EFFECTS; RADIOISOTOPES; THERAPY; VERTEBRATES
Optional Information
- Notes
- 15 refs, 2 tabs
- Secondary number(s)
- IAEA-SR--209/23